tiprankstipranks

Mani Foroohar Profile - Leerink Partners Analyst

179 Followers
tipranks
Mani Foroohar

Mani Foroohar
Leerink Partners

Wall Street Analyst
#6,557 out of 8,743 Wall Street Analysts
#20,125 out of 36,835 experts

Success Rate

47%
140 out of 299 ratings made a profit

Average Return

-0.90%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Mani Foroohar's trades since 2020 and holding each position for 1 Year would result in 46.82% of your transactions generating a profit, with an average return of -0.9% per rating.

Stock Rating Distribution

742Ratings
50.27% Buy
42.72% Hold
7.01% Sell
Distribution of Mani Foroohar's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Bridgebio Pharma
(BBIO)
Rating:Buy
Date:Jan 05, 2023 - Jan 05, 2024
Return:+390.70%
The most profitable rating made by Mani Foroohar

Mani Foroohar's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
EIDX
Eidos Therapeutics
Oct 05, 2020
Hold
Downgraded
4Ratings
67%
+42.93%
Sarepta Therapeutics
Nov 06, 2020
Buy
Reiterated
$197.00
(44.29% Upside)
3Ratings
33%
-1.53%
Adverum Biotechnologies
Oct 11, 2021
Hold
Reiterated
11Ratings
25%
-49.50%
Avrobio
Oct 19, 2021
Hold
Reiterated
7Ratings
0.00%
DRNA
Dicerna Pharma
Nov 14, 2021
Buy
Reiterated
16Ratings
100%
+48.20%
SIOX
Sio Gene Therapies
Feb 11, 2022
Hold
Reiterated
9Ratings
0%
-49.03%
Abeona Therapeutics
Nov 14, 2022
Hold
Reiterated
$6.00
(-14.04% Downside)
17Ratings
29%
-33.51%
AMYT
Amryt Pharma
Jan 09, 2023
Hold
Downgraded
16Ratings
75%
+56.10%
Tourmaline Bio
May 16, 2023
Hold
Reiterated
$20.00
(-45.46% Downside)
19Ratings
0%
-66.63%
Wave Life Sciences
May 23, 2023
Hold
Reiterated
$5.00
(13.38% Upside)
24Ratings
0%
-54.60%
List of latest recommendations made by Mani Foroohar. Click to expand and see Mani Foroohar's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Mani Foroohar activity FAQ

What is the performance of Mani Foroohar's recommendations?
The percentage of profitable recommendations made by Mani Foroohar is 47%, and the average return per transaction is -0.90%.
    What stocks does Mani Foroohar cover?
    Mani Foroohar mostly covers MRNA , BBIO , BLUE stocks.
      What was Mani Foroohar’s latest rating?
      Mani Foroohar latest rating was a hold on DBTX with a price target of ―, which represents an Upside of ―
        What was Mani Foroohar's most profitable rating?
        Mani Foroohar’s most profitable ratings was a buy on BBIO stock on Jan 05, 2023 - Jan 05, 2024. The return on the trade was +390.70%.
          Where can I see a list of stock analyst ratings?
          You can see a list of daily stock analyst ratings here.
            What are the most recommended stocks by analysts?
            You can see a list of the most recommended stocks by analysts here